North Star Investment Management Corp. - TAKEDA PHARMACEUTICAL CO LTD ownership

TAKEDA PHARMACEUTICAL CO LTD's ticker is TAK and the CUSIP is 874060205. A total of 348 filers reported holding TAKEDA PHARMACEUTICAL CO LTD in Q2 2019. The put-call ratio across all filers is 0.95 and the average weighting 0.3%.

Quarter-by-quarter ownership
North Star Investment Management Corp. ownership history of TAKEDA PHARMACEUTICAL CO LTD
ValueSharesWeighting
Q3 2021$4,0000.0%2560.0%0.00%
Q2 2021$4,000
-20.0%
2560.0%0.00%
Q1 2021$5,0000.0%2560.0%0.00%
-100.0%
Q4 2020$5,000
-50.0%
256
-53.7%
0.00%0.0%
Q3 2020$10,0000.0%5530.0%0.00%0.0%
Q2 2020$10,000
+25.0%
5530.0%0.00%0.0%
Q1 2020$8,000
-27.3%
5530.0%0.00%0.0%
Q4 2019$11,000
-15.4%
553
-26.7%
0.00%0.0%
Q3 2019$13,000
-23.5%
754
-8.5%
0.00%
-50.0%
Q1 2019$17,0008240.00%
Other shareholders
TAKEDA PHARMACEUTICAL CO LTD shareholders Q2 2019
NameSharesValueWeighting ↓
Y.D. More Investments Ltd 1,498,811$24,700,3805.57%
TFG Asset Management GP Ltd 1,903,662$31,372,3504.20%
Clean Yield Group 542,342$8,937,7963.81%
MANAGED ASSET PORTFOLIOS, LLC 1,467,952$24,1923.67%
Mondrian Investment Partners LTD 4,081,715$67,266,6631.48%
Sippican Capital Advisors 82,235$1,355,2331.30%
Psagot Value Holdings Ltd. / (Israel) 174,300$2,8301.18%
Clal Insurance Enterprises Holdings Ltd 4,365,500$71,9431.08%
Legacy Wealth Asset Management, LLC 123,303$2,032,0330.73%
BRANDES INVESTMENT PARTNERS, LP 1,817,972$29,960,1750.64%
View complete list of TAKEDA PHARMACEUTICAL CO LTD shareholders